Oncology Trends Impacting the Patient Experience, Trend 1


The ability to gain access to — and spend meaningful time with — oncologists is harder than ever.

June 01, 2016

Trend 1_Microcontent _r2Medical professionals have increasingly limited time to spend with pharmaceutical sales representatives. Physicians today - and oncologists in particular - are busier than ever, and the relentless demands on their time and energy mean less time and less willingness to interact with pharma sales reps.

Not only are most of today's oncologists treating larger numbers of patients, but given the complex nature of today's coverage landscape, the entire practice staff is also spending more time managing the administrative and logistical requirements associated with helping patients gain access to, and remain on, high-cost specialty medications.

Though many oncologists have less time to meet with knowledgeable pharma sales reps, their need for the types of support they can provide is stronger than ever. Each novel treatment option that emerges brings a new set of clinical and safety considerations, as well as complex reimbursement requirements and challenges, creating more demands on oncologists and their staff throughout the practice. Without sufficient information and support from the makers of these advanced therapy options, many prescribers find it difficult to manage all of the associated clinical and reimbursement complexity. And as the complexity continues to rise, a strong paradox has emerged: Reducing face time with pharma brand reps can make the work of the oncologist (and his or her office staff) harder, not easier.

Access the full ebook to learn more.  

Now available for download:


Sign in or register to leave a comment